Newborn Screening Market
Newborn Screening Market Size, Share & Trends Analysis Report by Product (Consumables, Instruments, Hearing Screening Instruments, Pulse Oximeters), by Test (Dry Blood Spot Tests, Hearing Screening Test, CCHD Screening Test), by Technology (Immune Assays & Enzymatic Assays, Tandem Mass Spectrometry, Molecular Assays, Hearing Screening Technologies), by End User (Clinical Laboratories, Hospitals), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)
|Forecast Years for Newborn Screening Market:||2022 - 2028|
|Historical Years for Newborn Screening Market:||2016 - 2021|
|Revenue 2021 for Newborn Screening Market:||USD 729.5 Million|
|Revenue 2028 for Newborn Screening:||USD 1164 Million|
|Revenue CAGR (2022 - 2028) for Newborn Screening Market :||8.1%|
|Fastest Growing Region (2022 - 2028) for Newborn Screening Market:||Asia Pacific|
|Largest Region (2021) for Newborn Screening Market:||North America|
The Global Newborn Screening Market was valued USD 729.5 Million in the year 2021 and is anticipated to reach a value of USD 1164 Million by the year 2028. The Global Market is forecasted to grow to exhibit a Compound Annual Growth Rate (CAGR) of 8.1% over the forecast period.
Newborn Screening is a public health program run by various hospitals in which newborn babies are screened and identified with rare but serious medical conditions (genetic, hormonal, or metabolic conditions) that can interfere with average growth but are easy to treat. Newborn Screening includes a variety of tests, such as hearing tests, urine tests, and dry blood tests, that are performed during the first few hours or days of an infant's life. These tests have the potential to help prevent a variety of health problems and deaths. From a simple urine and blood screening test to a more complex and comprehensive screening system capable of detecting many different conditions, Newborn Screening has developed. Newborn Screening tests detect various markers in an infant's blood that can increase or decrease if the infant has certain diseases.
Congenital Hypothyroidism, Phenylketonuria (PKU), Cystic Fibrosis (CF), and other metabolic conditions can now be diagnosed using newborn screening tests that affect fat metabolism or protein metabolism. Additionally, the increased incidence of heart disease and genetic disorders among newborns is expected to fuel the Global Newborn Screening Market. Furthermore, governmental and private organizations' initiatives and advancements in new technologies are propelling the Global Newborn Screening Market forward. However, on the other hand, insufficient facts among parents about neonatal screening, a shortage of skilled professionals, and inaccuracy in some tests are significant factors that may impede the growth of the Global Newborn Screening Market.
The Newborn Screening Market is segmented based on Product, Test, Technology, End User, and Region. Based on the segment Product, the market is further sub-segmented as Consumables Instruments, Hearing Screening Instruments, and Pulse Oximeters. Furthermore, based on the segment Tests, the market is sub-segmented into Dry Blood Spot Tests, Hearing Screening Tests, and CCHD Screening Tests. On the other hand, based on Technology, the market is sub-segmented as Immune Assays & Enzymatic Assays, Tandem Mass Spectrometry, Molecular Assays, Hearing Screening Technologies, Pulse Oximetry, and Other Technologies. Finally, the End-User segment is further categorized into sub-categories as Clinical Laboratories and Hospitals.
Based on Test:
Based on the segment Test, the Dried Blood Spot Tests (DBS) sub-segment is expected to maintain its dominance in the forecasted period. DBS sampling has been used for many years to screen newborn babies for congenital metabolic diseases. The benefits of DBS sampling include low volume requirements, Ease of occupying via finger or heel stick with minimal training, and Ease of transport and sample stability. In addition, this test can detect autism, lymphomas, leukemia, and other metabolic disorders. The advantage of Dried Blood Spot analysis is that it collects a small sample volume that can be easily moved. As a result, rising diseases in newborns are driving the market growth.
North America is projected to grow at the fastest CAGR during the forecast period
North America currently dominates the Newborn Screening Market and is expected to do so in the future. This is primarily due to the growing incidences of genetic diseases and mandatory testing in all 50 states of the U.S. The United States has observed the most extensive market growth in North America. This is primarily due to the growing incidence of newborn disorders and the increased demand for advanced systems. Every newborn in the United States is screened post-birth, with the analysis of diagnostic markers in blood spots collected on filter paper on the second day of an infant's life. However, Newborn Screening programs are run state-by-state in the United States due to a lack of consistency among testing panels in many states. However, with the growing incidence of genetic disorders and the increasing number of childbirths, Asia Pacific is expected to experience significant growth in the Global Newborn Screening Market. The evolving healthcare infrastructure, technological advancements, and increasing awareness about Newborn Screening are expected to drive the Newborn Screening Market growth in Latin America, the Middle East, and Africa during the forecast period.
The key players in the Global Newborn Screening Market include- PerkinElmer (US), Demant A/S (Denmark), Natus Medical (US), Bio-Rad Laboratories (US), Danaher Corporation (US), Medtronic (Ireland), Chromsystems Instruments & Chemicals GmbH (Germany), Trivitron Healthcare (India), Baebies (US), Recipe Chemicals+Instruments (Germany), and others.
Segmentation of the Global Newborn Screening Market:
Regions & Countries Covered
Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST
analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market
attractiveness analysis by segments and North America, company market share analysis, and COVID-19
Frequently Asked Questions
the global demand for Newborn Screening
in terms of revenue?
The global Newborn Screening valued at USD 729.5 Million in 2020 and is expected to reach USD 1164 Million in 2028 growing at a CAGR of 8.1%
are the prominent players
in the market?
The prominent players in the market are PerkinElmer (US), Demant A/S (Denmark), Natus Medical (US), Bio-Rad Laboratories (US), Danaher Corporation (US), Medtronic (Ireland), Chromsystems Instruments & Chemicals GmbH (Germany), Trivitron Healthcare (India), Baebies (US), Recipe Chemicals+Instruments (Germany).
At what CAGR is the market projected to grow within the forecast period?
The market is project to grow at a CAGR of 8.1% between 2021 and 2028.
the driving factors
fueling the growth of the market.
The driving factors of the Newborn Screening include
- Rising prevalence of newborn disorders
region accounted for the
largest share in the market?
North America was the leading regional segment of the Newborn Screening in 2020.